Janet Hammond
Corporate Officer/Principal chez ATEA PHARMACEUTICALS, INC.
Fortune : 142 862 $ au 31/03/2024
Profil
Janet Hammond is currently the Chief Development Officer at Atea Pharmaceuticals, Inc. and Vice President-Translational Medicine at Roche Ltd.
She previously worked as the Group Director-Virology Clinical Research at Bristol Myers Squibb Co., Chief Medical Officer, SVP & Head-Medical Affairs at Bausch Health Americas, Inc., SVP & Head-China Infectious Disease at F.
Hoffmann-La Roche Ltd., VP, Head-General Medicine & Infectious Disease at AbbVie, Inc., Head-Clinical Discovery at GSK Plc, and Senior Clinical Research Physician at Glaxo Wellcome, Inc. Hammond holds a doctorate from the University of Cape Town and a graduate degree from Johns Hopkins Bloomberg School of Public Health.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/02/2024 | 35 362 ( 0,04% ) | 142 862 $ | 31/03/2024 |
Postes actifs de Janet Hammond
| Sociétés | Poste | Début |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2020 |
Roche Ltd.
 Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Corporate Officer/Principal | 29/03/2011 |
Anciens postes connus de Janet Hammond
| Sociétés | Poste | Fin |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01/08/2020 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/11/2016 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Chief Tech/Sci/R&D Officer | 12/09/2011 |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | - |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
Formation de Janet Hammond
| University of Cape Town | Doctorate Degree |
| Johns Hopkins Bloomberg School of Public Health | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ABBVIE INC. | Health Technology |
| ATEA PHARMACEUTICALS, INC. | Health Technology |
| GSK PLC | Health Technology |
| Entreprise privées | 4 |
|---|---|
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Roche Ltd.
Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Finance |
| Glaxo Wellcome, Inc. | Health Technology |
